mGluR5-PKCγ signaling disrupts the AMPA receptor subunit homeostasis and drives central sensitization in chronic migraine
Neurochemistry International · 2026-11 · 106289
DOI: 10.1016/j.neuint.2026.106289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemistry International, 2026-11. Verfasst von Xiaojian Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, The First Affiliated Hospital of Chongqing Medical University, 1st You Yi Road, Yu Zhong District, Chongqing 400016, China. Die Arbeit nennt 74 Literaturangaben.
Abstract (Originalsprache)
Chronic migraine (CM) involves central sensitization in the trigeminal nucleus caudalis (TNC) and sustained glutamatergic transmission, which depends on AMPA receptor (AMPAR) subunit homeostasis-specifically, the equilibrium between GluA1 and GluA2 at the plasma membrane. Neurons may become hyperexcitable when this balance is disrupted, potentially due to the accumulation of calcium-permeable AMPARs. The impact of metabotropic glutamate receptor 5 (mGluR5) upregulation on AMPAR subunit homeostasis in CM remains unknown. Using a rat CM model established by recurrent dural infusion of an inflammatory soup (IS), we discovered that mGluR5 upregulation in the TNC was associated with an elevated GluA1/GluA2 ratio at the plasma membrane (surface), while total cellular GluA1 and GluA2 levels remained constant. The mGluR5 agonist CHPG worsened AMPAR subunit imbalance and pain hypersensitivity, whereas mGluR5 knockdown or the negative allosteric modulator MPEP corrected these abnormalities and reduced preexisting central sensitization. The PKC agonist phorbol 12-myristate 13-acetate (PMA) eliminated the protective effect of mGluR5 knockdown, suggesting that PKC acts as a downstream kinase. Mechanistically, mGluR5 activation leads to PKC activation, involving PKCγ, which lowers plasma membrane GluA2, increases GluA1 accumulation, and phosphorylates GluA1 at Ser849, collectively disturbing AMPAR subunit homeostasis. These findings suggest that the mGluR5-PKCγ-AMPAR signaling axis may contribute to central sensitization in CM. Moreover, by correcting the AMPAR subunit imbalance and alleviating pain hypersensitivity, targeting the allosteric site of mGluR5 with negative allosteric modulators (e.g., MPEP) may offer a therapeutic approach for CM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Central Laboratory, The First Affiliated Hospital of Chongqing Medical University, 1st You Yi Road, Yu Zhong District, Chongqing 400016, China.
- Central Laboratory, The First Affiliated Hospital of Chongqing Medical University, 1st You Yi Road, Yu Zhong District, Chongqing 400016, China. Electronic address: 273346692@qq.com.
- Central Laboratory, The First Affiliated Hospital of Chongqing Medical University, 1st You Yi Road, Yu Zhong District, Chongqing 400016, China. Electronic address: chenlixue@hospital.cqmu.edu.cn.
- Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. Electronic address: tangyishu111@163.com.
Zitieren
APA
Liu, X., Yang, Y., Zhong, J., Zhang, W., Wu, Q., Qin, G., Zhang, D., Wang, Y., Xian, Y., Tan, G., Chen, L., & Tang, Y. (2026). mGluR5-PKCγ signaling disrupts the AMPA receptor subunit homeostasis and drives central sensitization in chronic migraine. Neurochemistry International, 106289. https://doi.org/10.1016/j.neuint.2026.106289
Vancouver
Liu X, Yang Y, Zhong J, Zhang W, Wu Q, Qin G, et al. mGluR5-PKCγ signaling disrupts the AMPA receptor subunit homeostasis and drives central sensitization in chronic migraine. Neurochemistry International. 2026:106289. doi:10.1016/j.neuint.2026.106289
BibTeX
@article{Liu2026,
author = {Liu, Xiaojian and Yang, Yaying and Zhong, Juan and Zhang, Wei and Wu, Qing and Qin, Guangcheng and Zhang, Dunke and Wang, Yonghu and Xian, Yi and Tan, Ge and Chen, Lixue and Tang, Yishu},
title = {mGluR5-PKCγ signaling disrupts the AMPA receptor subunit homeostasis and drives central sensitization in chronic migraine},
journal = {Neurochemistry International},
year = {2026},
pages = {106289},
doi = {10.1016/j.neuint.2026.106289}
}
EUVIMED